La Vista, Neb. – Streck, Inc. and TK Biotech, a molecular biology and biotechnology of assisted reproduction products distributor in Poland, have signed a distribution agreement for Streck’s full portfolio of controls, cell stabilization and molecular products.
Streck’s cell stabilization products include Cyto-Chex® BCT, a blood collection tube for the preservation of whole blood specimens for immunophenotyping by flow cytometry; Cell-Free DNA BCT®, a direct-draw blood collection tube which stabilizes nucleated blood cells and prevents the release of genomic DNA, allowing isolation of high-quality cell-free DNA for a wide range of downstream applications commonly used in clinical research studies, drug discovery and diagnostic assay development; Cell-Free RNA BCT®, a blood collection tube with a patented preservative which stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage; and Cell-Free DNA Urine Preserve, a liquid reagent that stabilizes cell-free DNA in urine.
Streck’s Molecular Products division is focused on the generation of rapid diagnostic tools that impact healthcare decisions. Streck’s molecular product line includes the ARM-D® Kits for the detection of antibiotic resistance genes by multiplex real-time PCR and the soon-to-launch rapid real-time PCR instrument, the Zulu RT™, capable of 40 cycle reactions in 20 minutes or less.
Streck’s portfolio includes control products which test the performance and limits of instruments and reagents, helping laboratories meet regulatory and accreditation requirements.
About TK Biotech
Founded in 2001, TK Biotech is the exclusive representative in Poland of more than 30 global manufacturers of selected products in the field of molecular biology and biotechnology of assisted reproduction, which is characterized by constantly striving for innovation. Its partners’ products contribute to the development of modern diagnostics and treatment. The company’s team consists of specialists in the fields of molecular biology, biotechnology, biochemistry and biology, and provides its customers with professional consulting, support and assistance in the selection of optimal solutions.
About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry’s leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.